ENTPD1 and ovarian carcinoma: CD39+ CD73+ MDSCs have also been traced in ovarian cancer, where metformin treatment on MDSCs purified from peripheral blood of ovarian cancer patients or healthy donors showed promising results in restoring anti-tumor T-cell immunity by inhibiting HIF1α pathway [187].